Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, Colorado.
Department of Psychology, Colorado State University, Fort Collins, Colorado.
J Stud Alcohol Drugs. 2023 Jul;84(4):560-569. doi: 10.15288/jsad.21-00392. Epub 2023 Feb 1.
This study compared the efficacy of mindfulness-based relapse prevention (MBRP) with relapse prevention (RP) on reducing alcohol consumption. Secondary, exploratory aims assessed moderation of treatment effects by sex and cannabis use.
A total of 182 individuals (48.4% female; 21-60 years old) who reported drinking more than 14/21 drinks/week (for women and men, respectively) in the past 3 months but who wished to quit/reduce their drinking were recruited from Denver and Boulder, Colorado. Individuals were randomly assigned to 8 weeks of individual-based MBRP or RP treatment. Participants completed substance use assessments at baseline, halfway through and at the end of treatment, and 20 and 32 weeks after treatment. Primary outcomes were Alcohol Use Disorders Identification Test-consumption questions (AUDIT-C) scores, heavy drinking days (HDD), and drinks per drinking day (DDD).
Across treatments, drinking decreased over time ( < .001), with a significant time-by-treatment interaction found for HDD ( = 3.50, < .01). HDD initially decreased in both treatments but remained stable or increased after treatment for MBRP and RP participants, respectively. At follow-up, MBRP participants had significantly less HDD than RP participants. Sex did not moderate treatment effects ( > .17), whereas cannabis use moderated treatment effects on DDD and HDD ( = 4.89, < .001, and = 4.30, < .005, respectively). High cannabis use frequency was associated with continued posttreatment decreases in HDD/DDD for MBRP participants but increased HDD for RP participants. At low cannabis use frequency levels, HDD/DDD remained stable after treatment across groups.
Drinking decreases were comparable across treatments, but HDD improvements diminished for RP participants after treatment. In addition, cannabis use moderated treatment efficacy for HDD/DDD.
本研究比较了正念预防复发(MBRP)与预防复发(RP)在减少饮酒量方面的疗效。其次,探索性目的评估了性别和大麻使用对治疗效果的调节作用。
共招募了 182 名(48.4%为女性;年龄 21-60 岁)来自科罗拉多州丹佛和博尔德的个体,他们在过去 3 个月内报告每周饮酒超过 14/21 杯(女性和男性分别为),但希望戒酒或减少饮酒量。个体被随机分配到 8 周的个体为基础的 MBRP 或 RP 治疗中。参与者在基线、治疗中途和治疗结束时以及治疗后 20 和 32 周完成了物质使用评估。主要结局指标是酒精使用障碍识别测试-消费问题(AUDIT-C)评分、大量饮酒天数(HDD)和每日饮酒量(DDD)。
在治疗过程中,饮酒量随时间减少(<0.001),并且在 HDD 中发现了显著的时间-治疗相互作用(=3.50,<0.01)。HDD 在两种治疗中最初都减少了,但 MBRP 和 RP 参与者的治疗后保持稳定或增加。在随访时,MBRP 参与者的 HDD 明显少于 RP 参与者。性别未调节治疗效果(>.17),而大麻使用调节了 DDD 和 HDD 的治疗效果(=4.89,<0.001,和=4.30,<0.005)。高大麻使用频率与 MBRP 参与者治疗后 HDD/DDD 的持续减少相关,但与 RP 参与者的 HDD 增加相关。在低大麻使用频率水平下,各组治疗后 HDD/DDD 保持稳定。
治疗效果在两种治疗中相似,但 RP 参与者的 HDD 改善在治疗后减弱。此外,大麻使用调节了 HDD/DDD 的治疗效果。